InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,302.00
(
0.02%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
73.76
(
-0.18%
)
Bitcoin
63,481.49
(
-0.22%
)
Post# of 1434
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

rikic

Send PM Follow Ignore
Followers 2
Posts 298
Boards Moderated 0
Alias Born 08/16/2010

rikic

Re: rikic post# 1361

Thursday, 12/08/2016 10:21:16 AM

Thursday, December 08, 2016 10:21:16 AM

Post# of 1434
Does somebody know the reason?

Mayby this:

"We will review the next steps towards an application for approval of Pulmaquin in the U.S. at an upcoming meeting scheduled with FDA and are planning to engage soon in discussions of these results with the EMA as well," said Dr. Juergen Froehlich, MD, Aradigm's Chief Medical Officer.

http://investor.aradigm.com/releasedetail.cfm?ReleaseID=1001671
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up